Document:

Exhibit 4.4

 

long term Incentive Plan

 

DETAILED Plan rules

 

 

1.                       
  Introduction

 

The present rules are the plan rules (the Plan Rules) for grants
under the long term incentive plan (the Plan) to United States participants for
executives of such grades in ABB’s grading system as the Compensation Committee (the CC) may from time to time determine (such
executives herein referred to as “Eligible Executives”).

 

The Plan has been approved by the board of directors of ABB
Ltd (the ABB Board) upon the recommendation of the CC. 

 

In the Plan Rules the expression CC is for simplicity
reasons used also in situations where a decision or determination is made by
the ABB Board or (with respect to participants who are not on the Executive
Committee) the CEO of ABB Ltd.

2.                       
  General principles

2.1                   
  The Plan is offered by ABB Ltd to Eligible Executives as an
incentive for them to maximize long-term shareholder value of ABB Ltd. The Plan
thus helps align the interests of the Eligible
Executives with those of ABB.

2.2                   
  The Plan is not part of the salary of the respective Eligible
Executive and not part of his/her employment contract but is a voluntary,
separate and distinct opportunity outside the scope and reach of the employment
relation.

2.3                   
  Each Eligible Executive (subject to Section 3.1) will receive a
written invitation to participate in a launch under the Plan. Each Eligible
Executive who decides to participate in a launch under the Plan (Plan
Participant) will be granted shares of ABB Ltd (each a Share) on a conditional
basis (Conditional Grant). The number of Shares granted conditionally
(Conditional Share Grant Size) and the grant date (Grant Date) will be set
forth in a separate communication to each Plan Participant.  Failure to accept a
Conditional Grant will result in it being forfeited.

2.4                   
  Subject to what the CC may determine with respect to any grant, the
Shares to be received by each individual Plan Participant in respect of any grant will
vest on the first day (Vesting Date) following the end of the third year after
the Grant Date (such three-year period being the Vesting Period).  

 

For the purpose of the Plan Rules, a “Reference Period”
shall mean the period of time beginning 20 Trading Days prior to the date of
publication of the press release regarding ABB’s fourth quarter and full year
financial results (Press Release Date) and ending 20 Trading Days after the
Press Release Date.

 

For the purpose of the Plan Rules, a “Trading Day” is a day
when a closing price for transactions in Shares on the SIX Swiss Exchange is
available.

 

[1]

 

2.5                   
  The CC reserves the right not to grant all or a portion of any Conditional Grants
for any year or to terminate the Plan at any time without prejudice to Conditional Grants
that have not vested.  

2.6                   
  The Reference Price for all Conditional Grants under any
particular Plan will be the average of the closing prices of the
Share on the SIX Swiss Exchange on each Trading Day during the Reference Period
immediately preceding the Conditional Grant except the Press Release Date.  

3.                       
  Eligibility

3.1                   
  Subject to Section 3.2, participation in the Plan is restricted to
employees who are Eligible Executives on the Grant Date. No Eligible Executive
who has submitted a notice of termination of his/her employment or who has
received a termination notice from his/her employer or who has otherwise agreed
to leave his/her employer may participate in the Plan unless otherwise agreed
by the CC. The foregoing shall not apply if such Eligible Executive is or will
be employed by ABB Ltd or a subsidiary of ABB Ltd (collectively ABB).  Further,
the CC may at any time at its sole discretion determine that one or more
Eligible Executives shall not participate in the Plan. 

3.2             Notwithstanding anything contained herein to the
contrary, the CC may at its own discretion decide to invite a new Eligible
Executive to receive one or more Conditional Grants at a later date than
foreseen in Section 2.4 provided at least 6 months remain of the corresponding
Vesting Period. The Reference Price used to determine such Conditional Grants will
be the same as for the other Conditional Grants for that launch under the Plan.
Unless otherwise determined by the CC the following shall apply to each such
Conditional Grant:

a)   
  the Grant Date with respect
to such Conditional Grant shall be
the date set forth in the Grant confirmation letter;

b)   
  the Conditional Share Grant Size will be reduced to take into consideration the shorter period
of service of the new Eligible Executive except that no such reduction shall
occur in respect of Conditional Grants for which less than 6 months of the Vesting
Period has lapsed at the time when the individual becomes an Eligible Executive;

c)   
  the Vesting Period with
respect to each relevant Conditional Grant will not change; and

d)   
  a grant under this Section 3.2
shall be treated as a Conditional Grant for all purposes of the Plan.

4.                       
  Conditional Share Grants

4.1                   
  Conditional Share Grant

The CC will determine the criteria
relating to Conditional Share Grants for Plan Participants under this Plan,
including grant size, any applicable performance criteria (which may include
earnings per share, relative total shareholder return and/or such other
performance metrics as may be determined by the CC in its discretion), vesting,
settlement, and treatment of leavers, which criteria may vary from year to year
and from Plan Participant to Plan Participant.  All Conditional Share Grants
and the criteria applicable thereto shall be approved by the CC, and this
information will be separately communicated to the Plan Participants in writing
as part of the grant materials related to the relevant launch under this Plan. 

 

5.                       
  Change of Control

5.1                   
  For the purpose of the Plan, a “Change of Control”  means
the occurrence of any of the following events:

a) 
  the acquisition in one or
more transactions by any person or group, directly or indirectly, of beneficial
ownership of Shares representing more than fifty percent (50%) of the voting
rights pertaining to the total number of outstanding Shares; provided, however,
that any acquisition of Shares by ABB or any of its subsidiaries, or any
employee benefit plan (or related trust) sponsored or maintained by ABB or any
of its subsidiaries shall not constitute a Change of Control;

 

[2]

 

b)   the liquidation of ABB other than in connection with
the reorganization, merger or consolidation of ABB into or with another person
or entity, by which reorganization, merger or consolidation the persons who
held Shares representing one hundred per cent (100%) of the voting rights
pertaining to the total number of outstanding Shares prior to such reorganization,
merger or consolidation receive or continue to hold shares representing more
than fifty per cent (50%) of the voting rights pertaining to the total number
of outstanding shares of the new or continuing corporation; or

c)  
  the reorganization, merger
or consolidation of ABB into or with another person or entity, other than
in circumstances where as a result of such reorganization, merger or
consolidation the persons who held Shares representing one hundred percent
(100%) of the voting rights pertaining to the total number of outstanding
Shares prior to such reorganization, merger or consolidation receive or
continue to hold shares representing more than fifty per cent (50%) of the
voting rights pertaining to the total number of outstanding shares of the new
or continuing corporation.

 

5.2            If a Change of Control occurs, the terms and conditions of
the Conditional Share Grant remain unchanged. If, at the time of vesting, the
performance conditions associated with the award can no longer be applied, the
Conditional Share Grant will vest at the target achievement level. Furthermore,
if, at the Change of Control, ABB Shares are exchanged for another security,
then a corresponding change will be made to the number and definition of shares
under the Conditional Grant.

6.                  
  Forfeiture due to Illegal
Activity

 

6.1          In addition to any applicable forfeiture or
claw-back policies adopted by ABB from time to time, if ABB reasonably believes
that a Plan Participant has engaged in any illegal activity relating to his/her
employment with ABB Ltd or one of its subsidiaries, or
an error (including a misstatement or omission)  is found in any published
financial statements of ABB Ltd or one of its subsidiaries, requiring a
material downward restatement or which otherwise is material to ABB Ltd or the
subsidiary, then the ABB Ltd Board shall have the
right to determine, in its sole discretion, that all of such Plan Participant’s
Conditional Grants under this Plan that have
not yet vested, including any shares that are to vest after the Plan
Participant’s last day of employment, shall be forfeited.  The ABB Ltd Board
shall also have the right to require such Plan Participant to pay to ABB Ltd an
amount equal to the value, on delivery, of any Shares (including any portion
thereof settled in cash) delivered to such Plan Participant under this Plan.
ABB Ltd shall notify the relevant Plan Participant of any such decision.

7.                       
  Trading

 

7.1                   
  The trading platform established for this Plan is the principal
mechanism to be used for the sale of holdings arising under this Plan.

7.2                   
  Notwithstanding Section 7.1, the authorised ABB representative may
agree to facilitate the sale or transfer of all or a portion of such
holdings.  In such case, the ABB representative will accept verbal or
written instructions from the Plan Participant and communicate in writing such
instruction to the Plan Administrator. ABB and the Plan Administrator will be
held harmless by the Plan Participant when acting in accordance with such instructions.

8.                       
  Legal and regulatory
considerations

8.1                   
  Each Plan Participant must satisfy himself/herself that he/she is
entitled to receive and hold the Shares delivered hereunder as well as the
related Conditional Grants according to the laws to which he/she is subject as
resident and/or citizen. 

 

[3]

 

8.2                   
  The right to receive the Shares as well as the related Conditional Grants
and any subsequent sale of any Shares received will be subject to such
requirements, conditions, restrictions, limitations or prohibitions as may be
imposed for the purpose of complying with mandatory laws (including but not
limited to securities laws and insider trading laws) and regulations of
countries concerned.

8.3                   
  The Shares issued pursuant to the Plan may not be sold in the United States, unless pursuant to a registration statement or pursuant to an exemption from
registration under United States Securities Act of 1933, as amended. Plan
Participants are advised to consult with legal advisors as to any other applicable restrictions with regard to selling the Shares.

8.4                   
  The Plan Participants may be subject to securities law and/or
regulations on insider dealings in the respective jurisdictions. Therefore,
Plan Participants are advised to consult with legal advisors in their
jurisdiction as to any restrictions with regard to participating in the Plan or
dealing with Shares conveyed under the Plan. For avoidance of doubt, Plan
Participants are also reminded that they are required to comply with ABB policies
with respect to insider trading. 

9.                       
  Tax considerations

9.1                   
  Neither ABB Ltd nor any of its subsidiaries makes any
representation as to the tax consequences of participation in the Plan. Tax
consequences are difficult to predict and vary from country to country and from
time to time. Each Plan Participant therefore has to inform himself/herself of
the tax consequences of his/her participation in the Plan.

9.2                   
  There are circumstances where an existing or
former employer of a Plan Participant may be obliged to account for tax for
which the Plan Participant in question is liable in connection with the Plan.
The employer of each Plan Participant shall have the right to undertake any
measures relating to the Vested Award which it may consider suitable or required
in order to ensure that such tax is paid.  

9.3                   
  Social security charges which may be levied
on a Plan Participant by reason of his/her participation in the Plan will be
paid by the employer of the Plan Participant.

10.                   
  Variation of capital

10.1                
  In the event of (i) any variation of the share capital of ABB Ltd,
(ii) a demerger of any substantial business or direct or indirect subsidiary of
ABB Ltd, (iii) the payment of a special dividend by ABB Ltd, or (iv) another
comparable event as determined by the CC which occurs prior to the delivery of
any Shares, the CC will, based on advice from a financial institution, make
such adjustments (if any) to the relevant Conditional Share Grant Size of any
current Conditional Grants to which a Plan Participant may be entitled as it
considers appropriate in light of the occurrence of such event.

11.                   
  American Depository
Shares

11.1                
  For some Plan Participant(s) the Shares may be replaced by
American Depository Shares (ADS) representing Shares to the extent deemed appropriate
or necessary by ABB Ltd. In such instances and for the Plan Participants concerned,
 “Shares” shall be deemed to mean ADS except with respect to the definition of
Change of Control in Section 5.1 or as otherwise specified herein. Such ADS
shall be subject to the same selling restrictions as discussed in Section 8.3
above with respect to the Shares.

12.                   
  Implementation of and
Amendments to the present Plan Rules

12.1                
  The CC shall have the exclusive right to interpret the Plan Rules
and make all determinations foreseen to be made thereunder. In doing so, the CC may
at any time deviate from any provisions of the Plan Rules with respect to one
or more individual Plan Participants in connection with any unvested Conditional
Grant provided such deviation does not materially and adversely affect such
Plan Participant/s.

 

[4]

 

12.2                
  All conditions pertaining to the present Plan Rules are subject to
changes determined by the CC at any time provided that no such changes can be
made with respect to any unvested Conditional Grant if they would materially
and adversely affect the interests of the Plan Participants generally

13.                   
  Data privacy

 

For the sole purpose of administration and operation of the
Plan and Plan Participant’s participation in the Plan, personal data about the
Plan Participant (including data about transactions, shareholdings and benefits
derived from the Plan) may without prior notification to the Plan Participant: 

 

a)        
  be exchanged between his/her
employing company and ABB Ltd, Switzerland and any other party in any
jurisdiction within or outside the EU engaged by ABB Ltd for the administration
and/or operation of the Plan; and 

 

b)        
  be processed and/or stored
electronically or using other media by ABB Ltd, Switzerland and any other
party  in any jurisdiction within or outside the EU engaged by ABB Ltd for the
administration and/or operation of the Plan.

 

By deciding to participate in the Plan, the Plan Participant
consents to such exchange of and processing and storing of personal data during
and after termination of his/her employment.

 

In addition to the above, by deciding to participate in the Plan the Plan
Participant agrees that, during and after
termination of his/her employment, personal data
mentioned in this Section 14 may be disclosed at the request of tax- or other
authorities in countries where Plan Participants are or will be employed. 

 

For further general information about the processing of
your personal data, please read the employee data privacy notice
(https://new.abb.com/privacy-notice/employee)

14.                   
  Plan Terms Applicable to
US Plan Participants

 

14.1                
  Any Conditional Award granted under the Plan to a Plan Participant
to whom Section 409A of the Internal Revenue Code of 1986, as amended, of the
United States (the “Code”) may apply (a “US Plan Participant”) shall be subject
to this Section 14.

14.2                
  To the extent applicable, this Plan and the Conditional Grant
documentation thereunder shall be interpreted in accordance with Section 409A
of the Code and the Department of Treasury and other interpretive guidance
issued thereunder (collectively, “Section 409A”). Notwithstanding any other
provision of this Plan or any Conditional Grant documentation, if at any time
the CC determines that any Conditional Grant or payment with respect thereto
may be subject to Section 409A, the CC shall have the right in its sole
discretion (without any obligation to do so or to indemnify the US Participant
or any other person for failure to do so) to adopt such amendments to the Plan
or the applicable Conditional Grant documentation, or adopt other policies and
procedures (including amendments, policies and procedures with retroactive
effect), or take any other actions, as the CC determines are necessary or
appropriate for the Conditional Grants or any payment with respect thereto to
be exempt from the application of Section 409A or to comply with the
requirements of Section 409A. ABB makes no representations or warranties as to
the tax treatment of Conditional Grants or any payment with respect thereto
under Section 409A or otherwise. ABB shall have no obligation under this
Section 14.2 or otherwise  to take any action (whether or not described herein)
to avoid the imposition of taxes, penalties or interest under Section 409A with
respect to the Conditional Grants or any payment with respect thereto and shall
have no liability to the US Participant or any other person if any Conditional
Grants or any payment with respect thereto is determined to constitute
non-compliant "nonqualified deferred compensation" subject to the imposition
of taxes, penalties and/or interest under Section 409A. 

 

[5]

 

14.3                
  Notwithstanding anything in the Plan or any Conditional Grant
documentation to the contrary, the following provisions shall apply to each US
Plan Participant: 

 

a)      
  Vesting of any Conditional
Award and payment of any Shares shall be made in accordance with the Plan or any
Conditional Grant documentation thereunder upon and following a US Plan
Participant’s termination of employment only if such termination constitutes a
 "separation from service" from ABB and its subsidiaries within the
meaning of Section 409A(a)(2)(A)(i) of the Code (a “Separation from
Service”).  In the event that a US Plan Participant's termination of employment
does not constitute a Separation from Service, all Conditional Awards for which
the Vesting Period has not been completed as of the date of termination of
employment shall be forfeited and cancelled as of the date of termination of
employment, regardless of whether any applicable performance or other vesting criteria
have been achieved. 

 

b)      
  If a US Plan Participant is
a "specified employee" (within the meaning of Section 409A) at the
time of such US Plan Participant's Separation from Service, as determined by
the CC in its sole discretion, no amounts shall be paid to such US Plan Participant
under this Plan or any Conditional Grant documentation during the six (6)-month
period following such US Participant's Separation from Service to the extent
that the CC determines that payment of such amounts would constitute a
prohibited distribution under Section 409A(a)(2)(B)(i) of the Code. If the
payment of any such amounts is delayed as a result of the previous sentence,
then as soon as practicable after the end of such six (6)-month period (or the
date of the US Plan Participant's death, if earlier) (the “Delayed Payment
Date”), ABB shall pay to the US Plan Participant in a lump-sum such amounts
that would have otherwise been payable to the US Plan Participant prior to the
Delayed Payment Date. 

Any
acceleration of vesting or payment authorized by the CC pursuant to the Plan or
any Conditional Grant documentation in connection with a Change of Control shall
be provided to a US Plan Participant only if such Change of Control constitutes
a "change in control event" within the meaning of Section 409A. Any
such acceleration of vesting or payment must occur within the 30 day period
prior to the Change of Control and the US Plan Participant shall have no right
to designate the taxable year of payment.  

15.                   
  Governing Law and Dispute
Resolution

15.1                
  These Plan Rules and any other agreements entered into and any
documents issued or delivered in connection with the implementation of this
Plan are governed by Swiss substantive law.

15.2                
  Any dispute, controversy or claim arising under, out of or
relating to these Plan Rules, in particular as to their existence, validity,
interpretation, performance, breach or termination, including tort claims,
shall be decided by the commercial court of the Canton of Zurich.

 

 

[6]Exhibit
10.1

 

CONTRIBUTION
AGREEMENT

 

This
Contribution Agreement (this “Agreement”) is made as of the 2nd
day of April, 2021 (the “Effective Date”), by and between Medovex Corp., a Nevada corporation (the “Contributor”)
and Medovex, LLC, a Delaware limited liability company (the “Company”).

 

Background

 

The
Contributor owns certain personal property that the Company believes would be useful for or in the conduct of its business. This Agreement
contemplates a transaction (the “Transaction”) in which the Contributor will assign and contribute such personal property
and related rights, constituting all of the tangible assets of the Contributor relating to the DenerveX© rotational ablation denervation
device (the “DenerveX Device”) to the Company in exchange for the Consideration described herein.

 

Operative
Terms

 

The
parties, intending to be legally bound, agree as follows:

 

1.
Contribution and Assignment of Contributed
Assets.

 

(a)
Upon the terms and subject to the satisfaction or waiver,
if permissible, of the conditions of this Agreement, and in reliance upon the representations, warranties, and covenants contained in
this Agreement, at the Closing, the Contributor hereby contributes, assigns and conveys to the Company all right, title and interest
in and to all physical assets of the Contributor relating to the DenerveX Device identified on Exhibit A to this Agreement (collectively,
the “Contributed Assets”).

 

(b)
For the avoidance of doubt, the Contributed Assets shall
not include, and Contributor retains all right, title and interest in and to, any intangible assets of the Contributor relating to the
DenerveX Device, including any and all Intellectual Property Rights associated with the DenerveX Device. As used herein, “Intellectual
Property Rights” means all (i) patents and any and all reissues, divisions, continuations, renewals, re-examinations, extensions
and continuations-in-part thereof; (ii) inventions (whether patentable or not in any country), invention disclosures, improvements, trade
secrets, proprietary information, know-how and technical data; (iii) copyrights, mask works, copyright registrations, mask work registrations,
and applications therefor in any country, and all other rights corresponding thereto throughout the world; (iv) all fictional business
names, trademarks, trading names, service marks, trade dress, trade names, logos, internet domain names and company names and registrations
and applications for registration thereof together with all of the goodwill associated therewith, (v) other proprietary rights in technology,
including software (in source code and object code), algorithms, architecture, structure, display screens, layouts, application programming
interfaces and other components of and works embodied in the software (including any audio or visual content or screen displays in the
user interface), databases, development tools and all documentation and media constituting, describing or relating to the above, including,
without limitation, manuals, memoranda, records, business information, anywhere in the world, and all updates, upgrades, corrections,
modifications, translations, releases, versions and derivative works and improvements of each of the foregoing items; (vi) other intellectual
property rights and (vii) any applications, registrations, provisional applications or other filings for, or to obtain, protect, perfect,
or secure any of the foregoing, anywhere in the world.

 

    	 

     

    

 

(c)
The parties further agree that the Contributed Assets
shall not include the Contributor’s rights or obligations under that certain Contract for Distribution Center and Logistics Services
dated July 14, 2018, between TCB – Technology Consult Berlin GmbH (“TCB”) and the Contributor (as amended, the
“TCB Contract”). No later than thirty (30) days after the date hereof, the Company shall cause any Contributed Assets
held for storage by TCB pursuant to the TCB Contract to be removed and transported to another location not governed by the TCB Contract
of the Company’s choosing.

 

2.
Consideration for Contributed Assets.

 

(a)
As consideration for the Contributed Assets, the Company
shall issue to Contributor (i) the secured convertible promissory note in the original principal amount of $140,000 payable to the Contributor
(the “Seller Note”) and (ii) 400,000 Class B Units of the Company to the Contributor (the “Exchange Units”
and collectively with the Seller Note, the “Consideration”).

 

(b)
In its receipt of the Contributed Assets, the Company
hereby assumes any direct or indirect, primary or secondary, liability, indebtedness, obligation, penalty, cost or expense (including
costs of investigation, collection and defense), claim, deficiency, guaranty or endorsement of or by any Person (other than endorsements
of notes, bills, checks, and drafts presented for collection or deposit in the ordinary course of business) of any type, whether accrued,
absolute or contingent, known or unknown, liquidated or unliquidated, matured or unmatured, or otherwise directly and solely related
to the Contributed Assets.

 

3.
Closing; Further Assurances.

 

(a)
Closing. The closing of the contribution of the Contributed Assets shall take place on the Effective Date by electronic (i.e.,
email/PDF) or facsimile delivery of signature pages to the instruments and documents hereunder, with the exchange of original signatures
by overnight mail (the “Closing”). All proceedings to be taken and all documents to be executed and delivered by all
parties at the Closing shall be deemed to have been taken and executed simultaneously and no actions shall be deemed to have been taken
nor documents executed or delivered until all have been taken, executed and delivered.

 

(b)
Closing Deliveries of Contributor. Prior to or at the Closing, the Contributor shall deliver to the Company or shall cause to
be delivered to the Company (i) all certificates representing the Assets, if any, and (ii) a counterpart signature page to the Amended
and Restated Limited Liability Company Agreement of the Company dated as of the date hereof, by and among the Company, the Contributor
and other members signatory thereto.

 

(c)
Closing Deliveries of Company. At the Closing, the Company shall deliver to the Contributor (i) the Seller Note, duly executed
by the Company and (ii) evidence reasonably satisfactory to the Contributor that the Company has issued the Exchange Units to the Contributor
and has recorded such issuance on its books and records.

 

(d)
Further Assurances. Each party shall execute and deliver such instruments and other documents and take such other actions as may
reasonably be requested by any other party in order to consummate or implement the Transaction.

 

    	2

     

    

 

4.
Representations and Warranties of Contributor.
The Contributor represents and warrants to the Company that the statements
contained in this Section 4 are true, correct and complete as of the date of this Agreement.

 

(a)
Authority; Binding Obligation. The Contributor is a corporation duly incorporated, validly existing and in good standing under
the laws of the State of Nevada. The Contributor has the full corporate power and authority to enter into this Agreement and to assume
and perform its obligations under this Agreement and consummate the transactions contemplated hereby. The Contributor has duly executed
and delivered this Agreement and (assuming the due execution and delivery of the other parties to this Agreement) this Agreement constitutes
a valid and legally binding obligation of the Contributor, enforceable against the Contributor in accordance with its terms, except as
may be limited by bankruptcy, insolvency or other similar laws affecting the enforcement of creditors’ rights in general and subject
to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

 

(b)
Title; No Liens. The Contributor has good and transferable title to the Contributed Assets, and the Contributor is the sole owner
of such Contributed Assets. Neither the Contributor nor the Contributed Assets is subject to any pledge agreements, restriction agreements
or other document or instrument which affects the title to the Assets in any way or manner whatsoever. Upon the consummation of the Transaction,
the Contributed Assets will be conveyed to Company free and clear of any liens, claims or encumbrances of any third party whatsoever,
provided that the parties acknowledge and confirm that the Contributed Assets relating to Nortech and test kit inventories in the United
Kingdom are currently being held by third parties disputing the Contributor’s ownership of such assets. Following the Closing,
the Company shall be permitted to engage with such third parties to resolve any such disputes in its discretion and obtain title to such
assets.

 

5.
Representations and Warranties of Company.
The Company represents and warrants to the Contributor that the statements
contained in this Section 5 are true, correct and complete as of the date of this Agreement:

 

(a)
Authority; Binding Obligation. The Company is a limited liability company duly formed, validly existing and in good standing under
the laws of the State of Delaware. The Company has the full limited liability company power and authority to enter into this Agreement
and to assume and perform its obligations under this Agreement and consummate the transactions contemplated hereby. The Company has duly
executed and delivered this Agreement and (assuming the due execution and delivery of the other parties to this Agreement) this Agreement
constitutes a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except
as may be limited by bankruptcy, insolvency or other similar laws affecting the enforcement of creditors’ rights in general and
subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

 

(b)
Valid Issuance. The Exchange Units, when issued and delivered in accordance with the terms and for the consideration set forth
in this Agreement, will be validly issued and fully paid membership interests of the Company.

 

    	3

     

    

 

6.
Miscellaneous. 

 

(a)
Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of Delaware, without
regard to conflict of laws principles.

 

(b)
Entire Agreement; Amendment. This Agreement constitutes the entire agreement of the parties with respect to the Transaction, and
supersedes and terminates any prior agreements between the parties (written or oral) with respect to the subject matter hereof, including
any letter of intent. This Agreement may be amended only by the execution and delivery of a written instrument signed by or on behalf
of the Company and the Contributor.

 

(c)
Assignability; Binding Effect. This Agreement may not be assigned by any party without the prior written consent of the other
parties. This Agreement will be binding upon and will inure to the benefit of the parties and their respective successors, heirs, administrators
and permitted assigns.

 

(d)
Interpretation; Counterparts. The section captions used herein are for reference purposes only and shall not in any way affect
the meaning or interpretation of this Agreement. This Agreement may be signed in counterparts which when taken together shall constitute
one agreement binding on all the parties notwithstanding that not all the parties are signatories to the same counterpart. The exchange
of copies of this Agreement and of signature pages by facsimile transmission or electronic copy shall constitute effective execution
and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Whenever the singular
form is used in this Agreement, and when required by the context, the same shall include the plural and vice versa, and the masculine
gender shall include the feminine and neuter genders and vice versa.

 

(e)
Survival. All warranties, representations, and covenants made herein or in any certificate or other instrument delivered by the
parties hereto under this Agreement shall be considered to have been relied upon and shall survive the Closing.

 

(f)
Bulk Transfer Act. The parties hereby waive compliance with the bulk transfer provisions of the Uniform Commercial Code, or any
similar law as enacted in any jurisdiction, to the extent that it may be applicable to the transactions contemplated hereby.

 

(g)
Tax Treatment. For income tax purposes, the Company and the Contributor hereby acknowledge and agree that (i) immediately prior
to the admission of Contributor as a member of the Company, the Company was treated as a “disregarded entity” (within the
meaning of Treasury Regulations Section 301.7701-2(c)) for income tax purposes, and (ii) the transactions described herein shall be treated
for income tax purposes under Situation 1 of Revenue Ruling 99-5 (1999-1 C.B. 434) as a sale by Contributor of a portion of the Contributed
Assets for a purchase price equal to the original principal balance of the Seller Note and as a contribution by Contributor to the Company
of the remaining portion of the Contributed Assets in exchange for the Exchange Units in a tax-free transaction under Section 721 of
the Internal Revenue Code of 1986, as amended.

 

(h)
Transfer Taxes. All transfer, sales, use, excise, realty transfer, controlling interest, documentary stamp and other such taxes
and fees (“Transfer Taxes”) incurred in connection with the consummation of the transactions contemplated in this
Agreement (regardless of the Person on whom such taxes are imposed by applicable law) shall be paid by the Company when due, and the
Company will, at its own expense, file all necessary tax returns and other documentation with respect to all such Transfer Taxes, and
if required by applicable law, the Company will join in the execution of any such tax returns.

 

[Signature
page follows]

 

    	4

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Contribution Agreement as of the date first written above.

 

	 	Contributor:
	 	 
	 	MEDOVEX,
                                            CORP.,

    a
    Nevada corporation

	 	 
	 	By:	         
	 	Name:
    	 
	 	Title:	 

 

	 	Company:
	 	 
	 	MEDOVEX,
                                            LLC,

    a
    Delaware limited liability company

	 	 
	 	By:	         
	 	Name:
    	 
	 	Title:	 

 

Signature
Page to Contribution Agreement

 

    	 

     

    

 

Exhibit
A

 

Contributed
Assets

 

	 	●	Manufacturing
    Moulds (Nortech)
	 	 	 
	 	●	Manufacturing
    testing equipment (Nortech or Medovex)
	 	 	 
	 	●	BOM
	 	 	 
	 	●	Current
    and historic drawings
	 	 	 
	 	●	Current
    inventory
	 	 	 
	 	●	Spare
    Parts (Nortech)
	 	 	 
	 	●	Controllers
    held in the USA and Europe
	 	 	 
	 	●	Controllers
    held at distributors/customers to the extent owned and controlled by H-Cyte
	 	 	 
	 	●	Test
    Kit inventories (UK)
	 	 	 
	 	●	All
    marketing literature and conference assets
	 	 	 
	 	●	All
    marketing and labelling artwork
	 	 	 
	 	●	All
    Sales distributor agreements and Sales consultant agreements
	 	 	 
	 	●	All
    manufacturing agreements 
	 	 	 
	 	●	Any
    QC/QM agreements
	 	 	 
	 	●	Transfer
    of Grand Avenue licence

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]